Western herbalism
Lemon balmMelissa officinalis
A lemon-scented mint-family leaf used for tension and gas. We found no trial of lemon balm alone on the gut; infant colic and dyspepsia trials used multi-herb products.
- Botanical name
- Melissa officinalis
- Part used
- leaf
- Also called
- Balm, Melissa, Sweet balm, Bee balm (in older texts)
- Used in
- Western herbalism
- Taken for
- Bloating, Gas, Cramping and pain, Stress and the gut, Indigestion
- Sold as
- tea, capsules, tincture, liquid extract, essential oil
Lemon balm, the plant and the part used
Lemon balm is a perennial of the mint family (Lamiaceae) with lemon-scented leaves, native to Europe and the Mediterranean region and widely grown in gardens. The part used is the leaf, fresh or dried.
It is prepared as a tea (an infusion of the dried leaf), as a tincture or liquid extract, as a dry extract in capsules, and as a volatile oil used in aromatherapy and topical products. The oil is a separate product from the leaf tea and is not the preparation covered by the European monograph. Lemon balm also appears in combination products: a six-herb liquid for functional dyspepsia (bitter candytuft, chamomile, peppermint, caraway, licorice and lemon balm), and a chamomile, fennel and lemon balm extract sold for infant colic.
Because most of the published digestive work is on those combinations, the evidence below separates trials of the combination products from the herb on its own. A 2022 review describes lemon balm as used since ancient times for gastrointestinal, cardiovascular, neurological and psychological conditions, and lists anxiety, sleeping difficulties and infantile colic among the conditions tested in clinical settings.
Traditional uses, in their own terms
Western herbalism
The European Medicines Agency (EMA) monograph for Melissa leaf accepts lemon balm as a traditional herbal medicinal product for two indications: relief of mild symptoms of mental stress and to aid sleep, and symptomatic treatment of mild gastrointestinal complaints including bloating and flatulence. EMA states that the use is based exclusively on long-standing use, and its public summary describes the effectiveness as plausible while clinical evidence is limited. The monograph is for a leaf tea or equivalent preparation taken by mouth; it is a statement about European traditional practice, not a finding from trials.
Compounds, and what the laboratory says about them
The leaf contains rosmarinic acid (about 1.5 percent of dry leaf mass in one analysis), the triterpenoids ursolic and oleanolic acid, flavonoids, and a volatile oil that gives the lemon scent. In a laboratory assay a methanol extract inhibited rat brain GABA transaminase, an enzyme that breaks down the calming neurotransmitter GABA; rosmarinic acid accounted for 40 percent inhibition at 100 micrograms per milliliter. This is a cell-free lab result, offered as a possible mechanism for the calming use, not evidence of an effect in the gut. EMA also notes that in vitro and animal data indicate a water extract of the leaf may inhibit the activity of thyroid-stimulating hormone; the clinical relevance is not known.
Trials in people, with the numbers
We could find no randomized trial of lemon balm used alone for a digestive outcome. The human gut data are trials of products that contain it.
In functional dyspepsia, a double-blind trial of 120 patients tested STW 5-II, a six-herb liquid containing bitter candytuft, chamomile, peppermint, caraway, licorice and lemon balm. Symptom scores fell more with the product than placebo in the first 4 weeks (P < 0.001), and after 8 weeks 43.3 percent on active treatment and 3.3 percent on placebo reported complete symptom relief. A separate meta-analysis of the related preparation STW 5 (Iberogast) pooled three placebo-controlled studies (138 on active treatment, 135 on placebo) and found a better score for the most bothersome symptom (odds ratio 0.22, P = 0.001). Neither trial can isolate lemon balm from the other herbs.
In infant colic, a 2005 trial of 93 breastfed infants (88 finished) compared a chamomile, fennel and lemon balm extract with placebo twice daily for a week: average crying fell from 201.2 to 76.9 minutes a day versus 198.7 to 169.9 on placebo (P < 0.005). A later open randomized trial of 176 infants compared a chamomile, lemon balm and tyndallized Lactobacillus acidophilus product with simethicone for 28 days: 95 percent responded versus 68.4 percent on simethicone. The second was open-label, so participants knew what they were given.
Trials of lemon balm on anxiety and sleep sit outside the gut and are not reviewed here.
| Study | Dose | What it found |
|---|---|---|
| Double-blind trial, 120 patients with functional dyspepsia (six-herb product including lemon balm) PMID 14755152 | STW 5-II liquid, 4-week blocks, 8 weeks assessed | Complete symptom relief 43.3% vs 3.3% on placebo at 8 weeks (P < 0.001) |
| Meta-analysis of three placebo-controlled trials of STW 5 (multi-herb), 138 active vs 135 placebo PMID 15606389 | STW 5 (Iberogast) liquid | Better score for the most bothersome symptom (odds ratio 0.22, P = 0.001) |
| Double-blind placebo-controlled trial, 93 breastfed infants with colic (chamomile, fennel, lemon balm) PMID 16041731 | Standardized extract, twice daily for 1 week | Crying 201.2 to 76.9 min/day vs 198.7 to 169.9 on placebo (P < 0.005) |
| Open randomized trial, 176 infants with colic (chamomile, lemon balm and L. acidophilus HA122) PMID 28665038 | Product vs L. reuteri vs simethicone, 28 days | Response 95% vs 68.4% on simethicone (P < 0.001) |
The doses on record
The EMA monograph lists, for adults and adolescents over 12, a herbal tea of 1.5 to 4.5 g of the comminuted leaf in 150 ml of boiling water, 1 to 3 times daily; powdered leaf 0.19 to 0.55 g, 2 to 3 times daily; liquid extract 2 to 4 ml, 1 to 3 times daily; or a tincture of 2 to 6 ml, 1 to 3 times daily. Use in under-12s is not advised, and symptoms lasting longer than 2 weeks should go to a doctor or practitioner. The trial products had their own doses: STW 5-II was given over three 4-week blocks, the colic extract twice a day for a week. Those doses do not transfer to the tea.
None of this is a dose recommendation. It is what the literature used, set down so a label can be compared with it; a pharmacist or clinician decides what applies to you.
The safety record
EMA lists no known undesirable effects for the leaf. It notes that the leaf may impair the ability to drive and use machines, and that affected patients should not drive or operate machinery. Genotoxicity, reproductive toxicity and carcinogenicity tests have not been performed. Safety in pregnancy and breastfeeding has not been established, and EMA does not advise use during either.
The thyroid finding is a caution rather than a case report: in vitro and animal data suggest the water extract may inhibit thyroid-stimulating hormone, with unknown clinical relevance. A review of lemon balm trials describes reported adverse events as very rare. The infant colic trials of combination products reported no side effects in the 2005 trial.
Medicines it can interact with
EMA lists the interaction section as “no data available.” The leaf extract inhibited GABA transaminase in a laboratory assay, and EMA warns that the herb may impair the ability to drive and use machines, so additive drowsiness with other sedating substances is a reasonable question to ask a pharmacist, though no interaction study exists. EMA’s thyroid-stimulating hormone data are relevant in principle to people on thyroid medicines. Neither point has been tested in a clinical interaction study, and we found no reported medicine interactions for the leaf.
The interaction rules the quiz applies to lemon balm
These are the medicines the quiz pairs with a caution or an exclusion for this herb, taken from published interaction references:
- alprazolam (flagged to check)
- butabarbital (flagged to check)
- clonazepam (flagged to check)
- dapagliflozin (flagged to check)
- diabetes pills (flagged to check)
- diazepam (flagged to check)
- empagliflozin (flagged to check)
- eszopiclone (flagged to check)
- glimepiride (flagged to check)
- glipizide (flagged to check)
- glyburide (flagged to check)
- insulin (flagged to check)
- levothyroxine (flagged to check)
- liothyronine (flagged to check)
- liraglutide (flagged to check)
- lorazepam (flagged to check)
- mephobarbital (flagged to check)
- metformin (flagged to check)
- and 14 more
Where lemon balm turns up in the catalog
Lemon balm appears on the labels below, alone or inside a blend; each product page gives the printed amount, the evidence for that product and the review picture.
Match it to your own case
The quiz weighs your symptoms and medicines against every product researched here, lemon balm products included, and shows its working.
Take the quizRead next
Questions people ask
Has lemon balm alone been tested for digestion?
We could find no randomized trial of lemon balm alone on a gut outcome. The dyspepsia and infant colic trials all used multi-herb products. Those results cannot be assigned to lemon balm specifically.
What does the European monograph say it is for?
EMA accepts it as a traditional herbal medicine for mild stress symptoms and sleep, and for mild gastrointestinal complaints including bloating and flatulence. The monograph says the use rests only on long-standing use, with limited clinical evidence.
Is it used for infant colic?
Combination products containing lemon balm, chamomile and fennel were tested in infants in two trials. The EMA monograph for the leaf itself does not advise use in children under 12.
Does it affect the thyroid?
In vitro and animal data cited by EMA suggest a water extract may inhibit thyroid-stimulating hormone. The clinical relevance is not known, and no human thyroid study of the tea is cited.
Is lemon balm tea the same as lemon balm essential oil?
No. The monograph covers leaf tea, powder, liquid extract and tincture. The distilled oil is used in aromatherapy and topical products and was not part of the digestive trials we found.
Sources
- EMA/HMPC, "Community herbal monograph on Melissa officinalis L., folium", EMA/HMPC/196745/2012 www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-melissa-officinalis-l-folium_en.pdf
- Madisch A et al., "Treatment of functional dyspepsia with a herbal preparation. A double-blind, randomized, placebo-controlled, multicenter trial", Digestion 2004;69:45-52 pubmed.ncbi.nlm.nih.gov/14755152
- Melzer J et al., "Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast)", Aliment Pharmacol Ther 2004;20:1279-87 pubmed.ncbi.nlm.nih.gov/15606389
- Savino F et al., "A randomized double-blind placebo-controlled trial of a standardized extract of Matricariae recutita, Foeniculum vulgare and Melissa officinalis (ColiMil) in the treatment of breastfed colicky infants", Phytother Res 2005;19:335-40 pubmed.ncbi.nlm.nih.gov/16041731
- Martinelli M et al., "Efficacy of a standardized extract of Matricariae chamomilla L., Melissa officinalis L. and tyndallized Lactobacillus acidophilus (HA122) in infantile colic: An open randomized controlled trial", Neurogastroenterol Motil 2017;29 pubmed.ncbi.nlm.nih.gov/28665038
- Awad R et al., "Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity", Phytother Res 2009;23:1075-81 pubmed.ncbi.nlm.nih.gov/19165747
- Zam W, "An updated review on the properties of Melissa officinalis L.: Not exclusively anti-anxiety", Front Biosci (Schol Ed) 2022;14:16 pubmed.ncbi.nlm.nih.gov/35730441